Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,723331-   
Low Rs1,243238-   
Sales per share (Unadj.) Rs284.298.3-  
Earnings per share (Unadj.) Rs36.8-24.8-  
Cash flow per share (Unadj.) Rs57.7-20.5-  
Dividends per share (Unadj.) Rs22.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs183.177.2-  
Shares outstanding (eoy) m338.45168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.22.9 180.3%   
Avg P/E ratio x40.3-11.5 -350.9%  
P/CF ratio (eoy) x25.7-13.9 -185.5%  
Price / Book Value ratio x8.13.7 219.6%  
Dividend payout %59.80-   
Avg Mkt Cap Rs m501,77948,025 1,044.8%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m16,7773,014 556.6%   
Avg. sales/employee Rs Th03,866.4-  
Avg. wages/employee Rs Th0702.1-  
Avg. net profit/employee Rs Th0-974.2-  
INCOME DATA
Net Sales Rs m96,20216,598 579.6%  
Other income Rs m632116 543.9%   
Total revenues Rs m96,83416,715 579.3%   
Gross profit Rs m28,240-2,876 -981.8%  
Depreciation Rs m7,066716 986.3%   
Interest Rs m3,334450 741.6%   
Profit before tax Rs m18,472-3,926 -470.5%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,019245 2,453.6%   
Profit after tax Rs m12,452-4,182 -297.7%  
Gross profit margin %29.4-17.3 -169.4%  
Effective tax rate %32.6-6.2 -521.5%   
Net profit margin %12.9-25.2 -51.4%  
BALANCE SHEET DATA
Current assets Rs m53,13712,157 437.1%   
Current liabilities Rs m54,4736,840 796.4%   
Net working cap to sales %-1.432.0 -4.3%  
Current ratio x1.01.8 54.9%  
Inventory Days Days15111 14.0%  
Debtors Days Days7124 6.0%  
Net fixed assets Rs m91,3907,086 1,289.7%   
Share capital Rs m1,69277 2,196.0%   
"Free" reserves Rs m60,2880-   
Net worth Rs m61,98113,028 475.8%   
Long term debt Rs m24,9624,578 545.2%   
Total assets Rs m144,68224,611 587.9%  
Interest coverage x6.5-7.7 -84.6%   
Debt to equity ratio x0.40.4 114.6%  
Sales to assets ratio x0.70.7 98.6%   
Return on assets %10.9-15.2 -71.9%  
Return on equity %20.1-32.1 -62.6%  
Return on capital %25.1-19.8 -126.6%  
Exports to sales %21.80-   
Imports to sales %00-   
Net fx Rs m17,2590-   
CASH FLOW
From Operations Rs m23,6811,417 1,671.5%  
From Investments Rs m-24,153-435 5,552.1%  
From Financial Activity Rs m7744,155 18.6%  
Net Cashflow Rs m1,1015,137 21.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.56 Rs / ZAR

Compare TORRENT PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: ISHITA DRUGS  CONCORD DRUGS  AMI ORGANICS  GANGA PHARMACEUTICALS  MANGALAM DRUGS  



Today's Market

Gift Nifty Down 39 Points | Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today Gift Nifty Down 39 Points | Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended on firm footing.